Patents by Inventor Jacob Berger
Jacob Berger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12683893Abstract: Methods and systems for routing messages based on message priority. In some aspects, the system may determine paths between a source and one or more destinations. The system may determine, for a first message, using a machine learning model, a first predicted path having a first distance. The system may determine, based on the first predicted path, using a Markov decision process, a priority of the first message. Based on determining that a first confidence score for the first predicted path does not exceed a threshold, the system may select a different path for the first message. The system may select the different path based on the priority of the first message and a second distance associated with the different path. The system may then re-direct the first message along the different path.Type: GrantFiled: August 5, 2024Date of Patent: July 14, 2026Assignee: Capital One Services, LLCInventors: Jacob Berger, Charles DeVore, Xiaoyi Wang, Lindsey May, Waleed Algadhi, Linsu Han
-
Patent number: 12545913Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: GrantFiled: August 16, 2023Date of Patent: February 10, 2026Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Publication number: 20260039585Abstract: Methods and systems for routing messages based on message priority. In some aspects, the system may determine paths between a source and one or more destinations. The system may determine, for a first message, using a machine learning model, a first predicted path having a first distance. The system may determine, based on the first predicted path, using a Markov decision process, a priority of the first message. Based on determining that a first confidence score for the first predicted path does not exceed a threshold, the system may select a different path for the first message. The system may select the different path based on the priority of the first message and a second distance associated with the different path. The system may then re-direct the first message along the different path.Type: ApplicationFiled: August 5, 2024Publication date: February 5, 2026Applicant: Capital One Services, LLCInventors: Jacob BERGER, Charles DeVORE, Xiaoyi WANG, Lindsey MAY, Waleed ALGADHI, Linsu HAN
-
Publication number: 20250382663Abstract: Presented is a nucleic acid-guided nuclease cascade assay that can detect one or more target nucleic acids of interest of interest without the need for amplifying the target nucleic acids of interest. The nucleic acid-guided nuclease cascade assays utilize signal amplification mechanisms comprising various components including nucleic acid-guided nucleases and guide RNAs (gRNAs) forming ribonucleoprotein complexes, blocked primer molecules, template molecules, polymerases and reporter moieties.Type: ApplicationFiled: August 29, 2025Publication date: December 18, 2025Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
-
Patent number: 12410464Abstract: Presented is a nucleic acid-guided nuclease cascade assay that can detect one or more target nucleic acids of interest of interest without the need for amplifying the target nucleic acids of interest. The nucleic acid-guided nuclease cascade assays utilize signal amplification mechanisms comprising various components including nucleic acid-guided nucleases and guide RNAs (gRNAs) forming ribonucleoprotein complexes, blocked primer molecules, template molecules, polymerases and reporter moieties.Type: GrantFiled: February 25, 2024Date of Patent: September 9, 2025Assignee: VedaBio, Inc.Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
-
Publication number: 20250215428Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: January 31, 2025Publication date: July 3, 2025Inventors: Jacob Berger, Ashish Pandey, Ariana Mostafa, Anurup Ganguli
-
Publication number: 20250109399Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: ApplicationFiled: September 16, 2024Publication date: April 3, 2025Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Patent number: 12247205Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: August 15, 2024Date of Patent: March 11, 2025Assignee: VedaBio, Inc.Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Publication number: 20240401051Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: August 15, 2024Publication date: December 5, 2024Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Patent number: 12129468Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: GrantFiled: January 31, 2024Date of Patent: October 29, 2024Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Patent number: 12104158Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: February 23, 2024Date of Patent: October 1, 2024Assignee: VedaBio, Inc.Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Publication number: 20240218428Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: ApplicationFiled: February 25, 2024Publication date: July 4, 2024Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
-
Publication number: 20240218364Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° ° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: ApplicationFiled: January 31, 2024Publication date: July 4, 2024Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Publication number: 20240191234Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: February 23, 2024Publication date: June 13, 2024Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Patent number: 11987839Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: GrantFiled: September 24, 2023Date of Patent: May 21, 2024Assignees: VedaBio, Inc., The Board of Trustees of The University of IllinoisInventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey
-
Patent number: 11970730Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising and a blocking nucleic acid molecule represented by Formula III in the 5?-to-3? direction comprises: T-D-M-A-(B-L)J-C; wherein T is 17-135 nucleotides in length; D is 0-10 nucleotides in length; M is 1-25 nucleotides in length or is absent, wherein if M is absent then T-D and A-(B-L)J-C are separate nucleic acid strands; A is 0-15 nucleotides in length and comprises at least 50% sequence complementarity to D; B is 4-12 nucleotides in length and comprises at least 50% sequence complementarity to T; L is 3-25 nucleotides in length; J is an integer between 1 and 10; C is 4-15 nucleotides in length; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: GrantFiled: June 10, 2023Date of Patent: April 30, 2024Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey, Rashid Bashir
-
Publication number: 20240110251Abstract: Described herein are systems and methods which utilize an array of wells to rapidly detect target analytes from whole blood samples, even at very low concentrations. The provided systems and methods dry the blood sample to ensure a fluidic network forms in one or more dry blood sample islands and liquid with reagents useful for detecting nucleic acid sequences from a target analyte, including by amplification reactions that are bi-phasic because of the interaction between the solid dried blood sample phase and the liquid phases, including liquid having reagents that are able to fluidically and diffusively exchange with the fluidic network within the dried blood sample phase.Type: ApplicationFiled: September 25, 2023Publication date: April 4, 2024Inventors: Rashid BASHIR, Anurup Ganguli, Jongwon Lim, Ariana Mostafa, Enrique Andres Valera Cano, Matthew Wester, Jacob Berger
-
Patent number: 11946052Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: November 24, 2023Date of Patent: April 2, 2024Assignee: VedaBio, Inc.Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
-
Publication number: 20240102014Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: November 24, 2023Publication date: March 28, 2024Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
-
Publication number: 20240035028Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: ApplicationFiled: August 16, 2023Publication date: February 1, 2024Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger